Hsu Yun, Jubelin Gregory, Taieb Frédéric, Nougayrède Jean-Philippe, Oswald Eric, Stebbins C Erec
Laboratory of Structural Microbiology, Rockefeller University, New York, NY 10021, USA.
J Mol Biol. 2008 Dec 12;384(2):465-77. doi: 10.1016/j.jmb.2008.09.051. Epub 2008 Sep 27.
Bacterial pathogens have evolved a sophisticated arsenal of virulence factors to modulate host cell biology. Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) use a type III protein secretion system (T3SS) to inject microbial proteins into host cells. The T3SS effector cycle inhibiting factor (Cif) produced by EPEC and EHEC is able to block host eukaryotic cell-cycle progression. We present here a crystal structure of Cif, revealing it to be a divergent member of the superfamily of enzymes including cysteine proteases and acetyltransferases that share a common catalytic triad. Mutation of these conserved active site residues abolishes the ability of Cif to block cell-cycle progression. Finally, we demonstrate that irreversible cysteine protease inhibitors do not abolish the Cif cytopathic effect, suggesting that another enzymatic activity may underlie the biological activity of this virulence factor.
细菌病原体已经进化出一套复杂的毒力因子库来调节宿主细胞生物学。肠致病性大肠杆菌和肠出血性大肠杆菌(EPEC和EHEC)利用III型蛋白分泌系统(T3SS)将微生物蛋白注入宿主细胞。EPEC和EHEC产生的T3SS效应周期抑制因子(Cif)能够阻断宿主真核细胞周期进程。我们在此展示了Cif的晶体结构,揭示它是包括半胱氨酸蛋白酶和乙酰转移酶在内的酶超家族的一个不同成员,这些酶共享一个共同的催化三联体。这些保守活性位点残基的突变消除了Cif阻断细胞周期进程的能力。最后,我们证明不可逆的半胱氨酸蛋白酶抑制剂不会消除Cif的细胞病变效应,这表明另一种酶活性可能是这种毒力因子生物学活性的基础。